Strikingly, specific overexpression of mutated SOD1 in MNs does not drive ALS-like pathology, whereas specific SOD1 modulation in mouse skeletal muscle leads to an ALS phenotype including muscle atrophy and MN degeneration [17,18]. Here, SOD1 is linked to amyotrophic lateral sclerosis.